Position in INSM
as of Mar 31, 2026
· filed Apr 13, 2026
Position Value
$59,684,800
-$3,839,800 QoQ
Shares Held
365,000
0.0% QoQ
Ownership
0.168%
of shares outstanding
% of Portfolio
0.70%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in INSM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GATEWAY INVESTMENT ADVISERS LLC holds $101,169,023 across 9 Biotechnology names. INSM ranks #1 (59.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
This page
|
365,000 | $59,684,800 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
67,121 | $29,972,211 | |
| 3 | MRNA |
Moderna, Inc.
|
146,265 | $7,430,262 | |
| 4 | INCY |
Incyte Corp
|
18,024 | $1,696,418 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,251 | $744,788 | |
| 6 | REGN |
Regeneron Pharmaceuticals, Inc.
|
779 | $601,886 | |
| 7 | TECH |
BIO-TECHNE Corp
|
9,712 | $507,549 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
1,474 | $278,659 |
All Filings in INSM
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $59,684,800 | 365,000 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $63,524,600 | 365,000 | Shares | Sole | 2026-02-03 | |
| No filing history on record for this holder in this stock. | ||||||